Long-Term Efficacy and Safety of First- and Second-Generation Baroreflex Activation Devices in Refractory Hypertension: A Single Center Retrospective Analysis
{{output}}
Background: Baroreflex activation therapy (BAT) has emerged as a device-based therapy for resistant hypertension. Comparative evidence between first-generation (Rheos®) and second-generation (Barostim neo™) BAT systems remains ... ...
